| Description |
1 online resource (xi, 386 pages) : illustrations. |
|
text txt rdacontent |
|
computer c rdamedia |
|
online resource cr rdacarrier |
| Series |
Annual reports in medicinal chemistry ; v. 30
|
| Note |
Editor-in chief-in-chief: James A. Bristol. |
|
"Sponsored by the Division of Medicinal Chemistry of the American Chemical Society." |
| Bibliography |
Includes bibliographical references and indexes. |
| Note |
Print version record. |
| Summary |
Praise for the Series: "This series is one of the very few annual publications which justify the title of an absolute must for the pharmacologist, chemist, or physician who is interested in the chemistry of drug development."--Enzymologia "This book is strongly recommended for researchers, teachers, students, administrators - in short, anyone whose interests impinge on medicinal chemistry. In view of the work's documented reference value, it is a must for inlusion in the scientist's personal library."--Journal of Medicinal Chemistry "All topics are covered in sufficient depth, with extensive references, to allow either the specialist or the novice to be informed of the latest developments in a particular area of medicinal chemistry." --Norman Gilman, Hoffmann-La Roche, Inc, in the JOURNAL OF PHARMACEUTICAL SCIENCES Advances in Medicinal Chemistry continues to provide timely and critical reviews of important topics in medicinal chemistry together with an emphasis on emerging topics in the biological sciences, which are expected to provide the basis for entirely new future therapies. |
| Contents |
Front Cover; Annual Reports in Medicinal Chemistry, Volume 30; Copyright Page; CONTENTS; CONTRIBUTORS; PREFACE; SECTION 1. CENTRAL NERVOUS SYSTEM DISEASES; Chapter 1. Recent Progress in Serotonin (5-HT)1A Receptor Modulators; Chapter 2 Centrally Acting Analgesics; Chapter 3. Heterogeneity of Corticotropin Releasing Factor Receptors: Multiple Targets for the Treatment of CNS and Inflammatory Disorders; Chapter 4. Emerging Opportunities in Neuroinflammatory Mechanisms of Neurodegeneration 31; Chapter 5. Nicotinic Acetylcholine Receptors: Molecular Biology, Chemistry and Pharmacology |
|
Chapter 6. Neuronal Calcium ChannelsSECTION II. CARDIOVASCULAR AND PULMONARY DISEASES; Chapter 7. Vascular Proliferative Disease; Chapter 8. Anticoagulant Strategies Targeting Thrombin and Factor Xa; Chapter 9. Potassium Channel Openers; Chapter 10. Progress in the Development of Endothelin Receptor Antagonists; SECTION III. CANCER AND INFECTIOUS DISEASES; Chapter 11. Antibacterial Agents; Chapter 12. Bacterial Virulence as a Potential Target for Therapeutic Intervention; Chapter 13. Retinoids for the Treatment of Oncological Doseases |
|
Chapter 14. Biological Response Modification by B-D-GlucansChapter 15. Antiviral Agents; Chapter 16. Therapy of Helicobacter pylori Infections: Current Status and Future Directions; SECTION IV. IMMUNOLOGY, ENDOCRINOLOGY AND METABOLIC DISEASES; Chapter 17. Recent Advancements in the Discovery and Development of Agents for the Treatment of Diabetes 159; Chapter 18. Gonadotropin Releasing Hormone Antagonists; Chapter 19. Selective Cyclooxygenase Inhibitors; Chapter 20. ß3-Selective Adrenergic Receptor Agonists; Chapter 21. The T Cell -- Antigen Presenting Cell Interaction as a Site for |
|
Chapter 22. Chemokines as Therapeutic TargetsSECTION V. TOPICS IN BIOLOGY; Chapter 23. Gene Therapy: Progress, New Directions, and Issues; Chapter 24. SH2 and SH3 Domains: Choreographers of Multiple Signaling Pathways; Chapter 25. Programmed Cell Death Mediated by Members of the TNF Receptor; Chapter 26. Tyrosine Kinase Induced Mitogenesis: Breaking the Link with Cancer; SECTION VI. TOPICS IN DRUG DESIGN AND DISCOVERY; Chapter 27. Catalytic Antibodies; Chapter 28. Structure-Based Design from Flexible Ligands; Chapter 29. Applications of Biosensor Technology in Drug Discovery |
|
Chapter 30. Catalytic RNA (Ribozymes) as DrugsSECTION VII. TRENDS AND PERSPECTIVES; Chapter 31. To Market, To Market -- 1994; Chapter 32. Potential Use of Thalidomide in HIV/AIDS; Chapter 33. Educating Medicinal Chemists; Chapter 34. Research Investments in a Managed Care, Cost-Containment, Oligopsony; COMPOUND NAME, CODE NUMBER AND SUBJECT INDEX, VOLUME 30; CUMULATIVE CHAPTER TITLES KEYWORD INDEX, VOLUMES 1-30; CUMULATIVE NCE INTRODUCTION INDEX, 1983-1994; CUMULATIVE NCE INTRODUCTION INDEX, 1983-1994, BY INDICATION |
| Language |
English. |
| Subject |
Pharmaceutical chemistry -- Periodicals.
|
|
Clinical chemistry -- Periodicals.
|
|
Chimie pharmaceutique -- Périodiques.
|
|
Chimie clinique -- Périodiques.
|
|
MEDICAL -- Drug Guides.
|
|
MEDICAL -- Pharmacology.
|
|
MEDICAL -- Pharmacy.
|
|
MEDICAL -- Nursing -- Pharmacology.
|
|
Clinical chemistry
|
|
Pharmaceutical chemistry
|
| Genre/Form |
Periodical |
|
periodicals.
|
|
Periodicals
|
|
Periodicals.
|
|
Périodiques.
|
| Other Form: |
Print version: Annual reports in medicinal chemistry. Volume 30. San Diego : Academic Press, ©1995 9780120405305 |
| ISBN |
9780080583747 (electronic bk.) |
|
0080583741 (electronic bk.) |
|
012040530X (electronic bk.) |
|
9780120405305 (electronic bk.) |
|
9786611739911 |
|
6611739912 |
| Standard No. |
CHBIS 010355986 |
|
CHVBK 329770349 |
|
DEBSZ 405326327 |
|
DEBSZ 482452323 |
|
AU@ 000056662759 |
|
